Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Change in Inventory came in at -$139000.0 in Q4 2025, down 113.85% YoY from $1.0 million in Q4 2024, and down 150.36% on a QoQ basis from $276000.0 in Q3 2025.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 3 years of Change in Inventory data on file, last reported at -$139000.0 in Q4 2025.
- Quarterly Change in Inventory fell 113.85% year-over-year to -$139000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 320.73% YoY) and the FY2025 annual result came in at $1.3 million, up 320.73% from the prior year.
- Change in Inventory eased to -$139000.0 in Q4 2025, from $276000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $797000.0 in Q2 2025 to a low of -$502000.0 in Q3 2024.
- A 3-year average of $189916.7 and a median of $296000.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2024 — Change in Inventory tumbled 258.86% — and 2025, when it surged 896.25%.
- Tracing FENC's Change in Inventory over 3 years: stood at $401000.0 in 2023, then slumped by 116.21% to -$65000.0 in 2024, then sank by 113.85% to -$139000.0 in 2025.
- The last three Change in Inventory figures came in at -$139000.0 (Q4 2025), $276000.0 (Q3 2025), and $797000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -139,000.00 |
| Sep 30, 2025 | 276,000.00 |
| Jun 30, 2025 | 797,000.00 |
| Mar 31, 2025 | 344,000.00 |
| Dec 31, 2024 | -65,000.00 |
| Sep 30, 2024 | -502,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | 401,000.00 |
| Sep 30, 2023 | 316,000.00 |
| Jun 30, 2023 | 521,000.00 |
| Mar 31, 2023 | 342,000.00 |